fosaprepitant

Generic: fosaprepitant dimeglumine

Labeler: northstar rxllc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name fosaprepitant
Generic Name fosaprepitant dimeglumine
Labeler northstar rxllc
Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients

fosaprepitant dimeglumine 150 mg/5mL

Manufacturer
NorthStar RxLLC

Identifiers & Regulatory

Product NDC 16714-248
Product ID 16714-248_014ef0ec-f371-ccc7-e063-6294a90a7349
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA214616
Listing Expiration 2026-12-31
Marketing Start 2023-01-28

Pharmacologic Class

Classes
cytochrome p450 2c9 inducers [moa] cytochrome p450 3a4 inducers [moa] cytochrome p450 3a4 inhibitors [moa] neurokinin 1 antagonists [moa] substance p/neurokinin-1 receptor antagonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 16714248
Hyphenated Format 16714-248

Supplemental Identifiers

RxCUI
1731077
UPC
0316714248011
UNII
D35FM8T64X

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name fosaprepitant (source: ndc)
Generic Name fosaprepitant dimeglumine (source: ndc)
Application Number ANDA214616 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 150 mg/5mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (16714-248-01) / 5 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (1)

16714-248-01 1 VIAL, SINGLE-DOSE in 1 CARTON (16714-248-01) / 5 mL in 1 VIAL, SINGLE-DOSE

Ingredients (1)

fosaprepitant dimeglumine (150 mg/5mL)

Linked Drug Pages (1)

Fosaprepitant ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "014ef0ec-f371-ccc7-e063-6294a90a7349", "openfda": {"upc": ["0316714248011"], "unii": ["D35FM8T64X"], "rxcui": ["1731077"], "spl_set_id": ["df341f63-0fef-4411-a89b-6df6b9e792be"], "manufacturer_name": ["NorthStar RxLLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (16714-248-01)  / 5 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "16714-248-01", "marketing_start_date": "20230128"}], "brand_name": "Fosaprepitant", "product_id": "16714-248_014ef0ec-f371-ccc7-e063-6294a90a7349", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Neurokinin 1 Antagonists [MoA]", "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "product_ndc": "16714-248", "generic_name": "Fosaprepitant dimeglumine", "labeler_name": "NorthStar RxLLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fosaprepitant", "active_ingredients": [{"name": "FOSAPREPITANT DIMEGLUMINE", "strength": "150 mg/5mL"}], "application_number": "ANDA214616", "marketing_category": "ANDA", "marketing_start_date": "20230128", "listing_expiration_date": "20261231"}